Use of Darbepoetin Alfa for the Treatment of Chemotherapy-induced Anaemia in European Clinical Practice - Data From the CHOICE Study

被引：0
|
作者：
Van Belle, S. [1 ]
Galid, A. [2 ]
Karanikiotis, C. [3 ]
Wheeler, T. [4 ]
Pujol, B. [5 ]
Labourey, J. L. [6 ]
机构：
[1] Ghent Univ Hosp, B-9000 Ghent, Belgium
[2] Hanusch KH, Gynecol & Obstet, Vienna, Austria
[3] Euromed Kyanous Stavros Hosp, Theassaloniki, Greece
[4] Amgen Ltd, Int Dev, Uxbridge, Middx, England
[5] Amgen Europe, Int Dev, Zug, Switzerland
[6] Ctr Hosp Antoine Gayraud, Carcassonne, France
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71217-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [1] A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice
    Van Belle, S.
    Swieboda-Sadlej, A.
    Karanikiotis, C.
    Labourey, J. -L.
    Galid, A.
    Wheeler, T.
    Pujol, B.
    Aerts, J. G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (07) : 1079 - 1087
  • [2] Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study
    Aerts, J. G.
    Swieboda-Sadlej, A.
    Karanikiotis, C.
    Labourey, J. -L.
    Galid, A.
    Wheeler, T.
    Pujol, B.
    Van Belle, S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (07) : 1089 - 1099
  • [3] The use of darbepoetin alfa for the treatment of chemotherapy-induced anaemia
    Vansteenkiste, J
    Wauters, I
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 429 - 440
  • [4] Darbepoetin alfa in the treatment of chemotherapy-induced anaemia
    Wauters, Isabelle
    Vansteenkiste, Johan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (02) : 221 - 230
  • [5] EFFECTIVE MANAGEMENT OF CHEMOTHERAPY-INDUCED ANAEMIA IN CLINICAL PRACTICE USING DARBEPOETIN ALFA: FINAL DATA FROM THE CORRECT II STUDY
    Steinmetz, H. T.
    Lange, O.
    Vehling-Kaiser, U.
    Kindler, M.
    Soeling, U.
    Kuhn, A.
    Hellebrand, E.
    Eggert, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 505 - 506
  • [6] Darbepoetin alfa: a new approach to the treatment of chemotherapy-induced anaemia
    Vansteenkiste, J
    Rossi, G
    Foote, M
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2003, 3 (03) : 501 - 508
  • [7] Darbepoetin alfa vs epoetin alfa in chemotherapy-induced anaemia
    Reactions Weekly, 2005, 1056 (1) : 5 - 5
  • [8] Current practice use of darbepoetin alfa in the management of chemotherapy-induced anaemia in patients <65 and ≥65 years: interim data from CHOICE, an international, observational study
    Van Belle, S.
    Dalivoust, P.
    Reinthaller, A.
    Tzanninis, D.
    Urbanski, K.
    Hamilton, L.
    Pujol, B.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 72 : S51 - S52
  • [9] First comparison of biosimilar epoetin alfa and darbepoetin alfa for the treatment of chemotherapy-induced anaemia
    Lorenz, A.
    Heine, O.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S295 - S295
  • [10] DARBEPOETIN ALFA IN THE TREATMENT OF CHEMOTHERAPY-INDUCED ANAEMIA; EFFECTS OF TARGET HAEMOGLOBIN LABEL CHANGE: DATA FROM THE APRIORI STUDY
    Sarosi, V.
    Cipkova, A.
    Mocikova, H.
    Wojciechowska-Lampka, E.
    Ocvirk, J.
    Balazs, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 386 - 386
12345